Monday, December 23, 2024
HomeTagsSecond-Line Esophageal

Second-Line Esophageal

China NMPA Approves Tislelizumab for Patients with Second-Line Esophageal Squamous Cell Carcinoma

BeiGene, Ltd., a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, announced...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics